Arcus Biosciences, Inc. Quarterly Current Ratio in % from Q3 2018 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Arcus Biosciences, Inc. quarterly Current Ratio history and growth rate from Q3 2018 to Q2 2024.
  • Arcus Biosciences, Inc. Current Ratio for the quarter ending June 30, 2024 was 483 %, a 15.6% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 483 -89 -15.6% Jun 30, 2024
Q1 2024 490 -128 -20.8% Mar 31, 2024
Q4 2023 500 -170 -25.4% Dec 31, 2023
Q3 2023 525 -201 -27.7% Sep 30, 2023
Q2 2023 572 -106 -15.7% Jun 30, 2023
Q1 2023 618 -17.3 -2.72% Mar 31, 2023
Q4 2022 670 +75.8 +12.7% Dec 31, 2022
Q3 2022 726 +182 +33.4% Sep 30, 2022
Q2 2022 678 +107 +18.8% Jun 30, 2022
Q1 2022 636 +12.3 +1.98% Mar 31, 2022
Q4 2021 594 -33.9 -5.4% Dec 31, 2021
Q3 2021 544 -116 -17.5% Sep 30, 2021
Q2 2021 571 -413 -42% Jun 30, 2021
Q1 2021 623 -239 -27.7% Mar 31, 2021
Q4 2020 628 -342 -35.2% Dec 31, 2020
Q3 2020 660 -456 -40.9% Sep 30, 2020
Q2 2020 984 -277 -22% Jun 30, 2020
Q1 2020 862 -642 -42.7% Mar 31, 2020
Q4 2019 970 -703 -42% Dec 31, 2019
Q3 2019 1.12K -537 -32.5% Sep 30, 2019
Q2 2019 1.26K Jun 30, 2019
Q1 2019 1.5K Mar 31, 2019
Q4 2018 1.67K Dec 31, 2018
Q3 2018 1.65K Sep 30, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.